Document Detail


Medical consumption and costs during a one-year follow-up of patients with LUTS suggestive of BPH in six european countries: report of the TRIUMPH study.
MedLine Citation:
PMID:  16314039     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To determine the medical consumption and associated treatment costs of patients with LUTS suggestive of BPH. METHODS: A prospective, cross-sectional, observational survey in six European countries: France, Germany, Italy, Poland, Spain and the United Kingdom, with a one-year follow-up of incident and prevalent patients. RESULTS: Treatment costs were estimated for 5,057 patients with a mean age of 66 years and a mean IPSS score at inclusion of 11.5. In 30% of patients watchful waiting was the therapy of choice for the full follow-up period, 57% were prescribed alpha-lockers, 11% finasteride and 10% phytotherapy at any moment during the follow-up (including switches and combination of treatment). Surgery rate was 4.9%. Mean one-year treatment costs were 858 per patient, three quarters of which concerned medication costs. Multivariate regression analysis showed that medication choice, complications and undergoing surgery were associated with higher costs. CONCLUSIONS: Treatment costs for patients with LUTS suggestive of BPH were moderate and largely consisted of medication costs. Daily practice and associated costs varied considerably across the six countries.
Authors:
N J A van Exel; M A Koopmanschap; J McDonnell; C R Chapple; R Berges; F F H Rutten;
Related Documents :
8945039 - Dual chamber pacing with a single lead system: initial clinical results.
16855499 - When is enophthalmos "significant"?
17532409 - Absence of correlation between symptoms and rhythm in "symptomatic" atrial fibrillation.
8772759 - Effects of oral propafenone administration before electrical cardioversion of chronic a...
1615799 - Risk factors for systemic embolism in patients with paroxysmal atrial fibrillation.
9793089 - Paroxysmal atrial fibrillation and high degree av block: use of single-lead vddr pacing...
11100989 - Intestinal failure.
23428069 - Insurance status, stone composition, and 24-hour urine composition.
24064019 - Lectin-like oxidised ldl receptor-1 as a marker of endothelial dysfunction in behçet's ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2005-11-02
Journal Detail:
Title:  European urology     Volume:  49     ISSN:  0302-2838     ISO Abbreviation:  Eur. Urol.     Publication Date:  2006 Jan 
Date Detail:
Created Date:  2005-12-19     Completed Date:  2006-05-16     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7512719     Medline TA:  Eur Urol     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  92-102     Citation Subset:  IM    
Affiliation:
Institute for Medical Technology Assessment (iMTA), Erasmus MC, Rotterdam, The Netherlands. n.vanExel@ErasmusMC.nl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Costs and Cost Analysis
Cross-Sectional Studies
Delivery of Health Care / utilization
Europe
Follow-Up Studies
Humans
Male
Middle Aged
Prospective Studies
Prostatic Hyperplasia / complications
Time Factors
Urination Disorders / economics*,  etiology,  therapy*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Failure to achieve castration levels in patients using leuprolide acetate in locally advanced prosta...
Next Document:  Relationship of safety culture and process safety.